Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma

Detalles Bibliográficos
Autores principales: Ailawadhi, Sikander, Panjabi, Sumeet, Campioni, Marco, Majer, Istvan, Jakubowiak, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397654/
https://www.ncbi.nlm.nih.gov/pubmed/29952705
http://dx.doi.org/10.18553/jmcp.2018.24.7.711
_version_ 1785083951186968576
author Ailawadhi, Sikander
Panjabi, Sumeet
Campioni, Marco
Majer, Istvan
Jakubowiak, Andrzej
author_facet Ailawadhi, Sikander
Panjabi, Sumeet
Campioni, Marco
Majer, Istvan
Jakubowiak, Andrzej
author_sort Ailawadhi, Sikander
collection PubMed
description
format Online
Article
Text
id pubmed-10397654
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103976542023-08-04 Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma Ailawadhi, Sikander Panjabi, Sumeet Campioni, Marco Majer, Istvan Jakubowiak, Andrzej J Manag Care Spec Pharm Letters Academy of Managed Care Pharmacy 2018-07 /pmc/articles/PMC10397654/ /pubmed/29952705 http://dx.doi.org/10.18553/jmcp.2018.24.7.711 Text en Copyright © 2018, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Letters
Ailawadhi, Sikander
Panjabi, Sumeet
Campioni, Marco
Majer, Istvan
Jakubowiak, Andrzej
Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma
title Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma
title_full Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma
title_fullStr Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma
title_full_unstemmed Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma
title_short Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma
title_sort reframing the value of treatments for relapsed/refractory multiple myeloma
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397654/
https://www.ncbi.nlm.nih.gov/pubmed/29952705
http://dx.doi.org/10.18553/jmcp.2018.24.7.711
work_keys_str_mv AT ailawadhisikander reframingthevalueoftreatmentsforrelapsedrefractorymultiplemyeloma
AT panjabisumeet reframingthevalueoftreatmentsforrelapsedrefractorymultiplemyeloma
AT campionimarco reframingthevalueoftreatmentsforrelapsedrefractorymultiplemyeloma
AT majeristvan reframingthevalueoftreatmentsforrelapsedrefractorymultiplemyeloma
AT jakubowiakandrzej reframingthevalueoftreatmentsforrelapsedrefractorymultiplemyeloma

Ejemplares similares